Cross-Border Impact Ventures

OXcan is a startup that focuses on early detection of lung cancer using advanced machine learning and liquid biopsy technologies. The company has developed an artificial intelligence-based healthcare platform that identifies cancer by analyzing targeted blood tests. This platform detects cancer-related materials released into the bloodstream, allowing for cost-effective and routine screening. By evaluating multidimensional liquid biopsy results, which include DNA, proteins, epigenetic markers, and patient medical histories, OXcan enables healthcare providers to achieve early cancer detection and implement curative treatment strategies.

OncoLens is a healthcare technology company that develops software solutions aimed at improving cancer care coordination and treatment planning. Their primary product is a HIPAA-compliant, mobile and web-based platform that integrates diverse data sets, oncology care teams, and stakeholders onto a single platform. This platform facilitates multi-disciplinary treatment planning, tumor board discussions, life-science commercial efforts, clinical trials enrollment, and payor authorizations. It also incorporates AI-driven clinical decision support capabilities to enhance the quality of cancer patient care.

Raydiant Oximetry, Inc. is a medical device company established in 2015 and headquartered in Mountain View, California. The company specializes in the development of a low-cost, non-invasive device that monitors fetal oxygen levels during labor, with the aim of improving health outcomes for mothers and their babies. By providing real-time data on fetal oxygenation, Raydiant Oximetry's technology seeks to enhance patient care, reduce the occurrence of unnecessary cesarean sections, and lower healthcare costs associated with childbirth. The company's innovations are designed to address potential birth injuries and minimize over-intervention in the delivery process, ultimately striving to improve the overall experience and safety of childbirth.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in women's pelvic health, particularly addressing the medical and social challenges associated with urinary and fecal incontinence. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic designed for at-home treatment of urinary incontinence and chronic fecal incontinence. The system employs patented technology that allows for non-invasive, drug-free treatment by providing real-time visualization of pelvic floor movements while tracking usage and progress. This approach empowers women to strengthen their pelvic floor and alleviate symptoms related to various types of incontinence, including stress, mixed, and urgency incontinence, ultimately improving their quality of life.

OncoLens is a healthcare technology company that develops software solutions aimed at improving cancer care coordination and treatment planning. Their primary product is a HIPAA-compliant, mobile and web-based platform that integrates diverse data sets, oncology care teams, and stakeholders onto a single platform. This platform facilitates multi-disciplinary treatment planning, tumor board discussions, life-science commercial efforts, clinical trials enrollment, and payor authorizations. It also incorporates AI-driven clinical decision support capabilities to enhance the quality of cancer patient care.

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Daye Ltd is a gynecological health company based in London, United Kingdom, founded in 2018. It specializes in developing and marketing female hygiene products under the Your Daye brand. The company offers innovative tampons, including CBD-infused options designed to alleviate menstrual cramps, providing an alternative to traditional pain relief methods. In addition to its tampon products, Daye has created an at-home vaginal microbiome screening kit that allows women to test for infections and microbiome disruptions at their convenience, addressing health issues such as thrush and bacterial vaginosis. Furthermore, Daye plans to launch a digital platform focused on gynecological health, aimed at supporting women throughout their health journeys from menstruation to menopause while reducing associated pain and stigma.

Macro-Eyes, Inc. is a machine learning company focused on enhancing access to healthcare through its innovative solutions. Its primary product, Sibyl, employs artificial intelligence for intelligent patient scheduling, which has shown a capability to improve patient utilization by 15%, enabling healthcare providers to see more patients without extending clinical hours. This technology is built on extensive research and deployment of AI for clinical decision support at prominent institutions, including Stanford University and major health systems in the United States. The company has garnered support from the Bill & Melinda Gates Foundation to develop a predictive supply chain for health, aimed at optimizing resource allocation at individual health facilities and pharmacies to prevent stock-outs and reduce waste. Additionally, Macro-Eyes is collaborating with the California Primary Care Association to implement Sibyl across 1,800 health facilities, thereby furthering its mission to increase access to life-saving care.